Moreover, ATM inhibition may represent an effective strategy in cancers with impairment of other DDR genes due to synthetic lethality, a phenomenon known to significantly impact sensitivity to other DDR-directed cancer drugs, such as PARP inhibitors (13, 14). Here, ATM is linked to cancer.